REITWAVE.COM Institutional Equity Tear Sheet Generator
Download Vector PDF Export Model (CSV)
REITWAVE.COM | INSTITUTIONAL REAL ESTATE RESEARCH
AS OF: OCTOBER 24, 2026  |  10Y TREASURY: 4.99%  |  SIC 6798

American Healthcare REIT, Inc. ($AHR)

Sector: Healthcare Facilities  •  Exchange / CIK: NYSE / 0001632970  •  Properties: 150 Assets
Trading at a 8.3% discount to NAV
Safety Score: 72/100 (Moderate Risk)  |  Credit: BBB

Live Share Price

$53.02
52W Range: $43.33 - $58.70

Valuation Multiples

14.0x P/AFFO
P/FFO: 13.0x  |  FFO/sh: $4.09

Net Asset Value (NAV)

$57.79
Prem/Disc: -8.3%  |  Cap: 6.54%

Dividend Cash Flow

5.58% Yield
$2.96/yr (Quarterly)  |  Payout: 78.1%
Balance Sheet & Debt Maturity Sentry
Net Debt to EBITDAre stands at 5.6x. Portfolio leased occupancy is 90.0% with a weighted average lease term (WALT) of 6.5 years. Senior credit rating of BBB provides institutional capital markets access for debt refinancing.
Recent Dividend Payment History (Last 6 Declarations)
Ex-Dividend Date Record / Pay Date Cash Distribution Status / Corporate Action
2026-09-30 2026-10-15 $0.7400 Regular Distribution
Representative Commercial Asset Concentrations (From SEC Form 10-K Item 2)
Commercial Asset / Property Name Location Rentable Sq Ft Occupancy Implied Asset Valuation
American Healthcare REIT, Inc. Flagship Commercial Portfolio United States Nationwide 18,750,000 sq ft (implied) 90.0% $8,668,500,000
Quantitative Risk & Benchmark Performance (QuantStats • VNQ)
Empirical 252-day trading window compared to Vanguard Real Estate ETF (VNQ) benchmark
METHODOLOGY: QUANTSTATS / CAPM
Beta vs VNQ
0.88
Index Tracking (Market Neutral)
Annualized Alpha (α)
+19.10%
Outperforming VNQ
Sharpe Ratio (vs VNQ)
0.73 vs 0.04
+0.69 Spread
Max Drawdown (1-Yr)
-14.1% vs -11.4%
-2.7% vs VNQ
AHR vs VNQ QuantStats Performance & Underwater Drawdown
Quantitative Risk & Return Metric AHR VNQ (Benchmark) Institutional Delta / Spread
Beta (β) vs VNQ
Covariance sensitivity to US REIT market
0.88 1.00 -0.12 (Index Tracking (Market Neutral))
Annualized Alpha (α)
Excess CAPM risk-adjusted performance
+19.10% 0.00% (Baseline) Outperforming VNQ
Sharpe Ratio (Rf = 4.5%)
Annualized excess return per unit of volatility
0.73 0.04 +0.69
Sortino Ratio
Downside semi-variance risk-adjusted return
0.73 0.03 +0.70
Annualized Volatility (σ)
Standard deviation of daily price returns × √252
25.9% 13.9% +12.0% (Higher Volatility)
Maximum Drawdown (1-Year)
Peak-to-trough capital decline over trailing 12M
-14.1% -11.4% -2.7% vs VNQ
1-Year Trailing Return (CAGR)
Compounded annual growth rate
22.3% 4.1% +18.2% Spread
R-Squared (R²) & Correlation
Statistical correlation coefficient against VNQ
R² 0.22 Corr: 0.47 22% variance explained by VNQ
Trading Session Win Rate
Percentage of positive daily closing sessions
53.2% 51.6% +1.6% vs Benchmark
QuantStats Analytical Synthesis: AHR displays a Beta of 0.88 relative to VNQ with 0.22 R² correlation. Annualized volatility is 25.9% (12.0% higher than VNQ at 13.9%). Trailing 12-month Alpha stands at +19.10% (Outperforming VNQ) with a Sharpe ratio of 0.73 against 0.04 for VNQ, and a maximum drawdown of -14.1%.
SEC CIK: 0001632970  |  Principal Executive Officer: Danny Prosky  |  Total PEO Compensation: $4,750,000 (54:1)
Official SEC Accession: 0001632970-26-000018
CONFIDENTIAL INSTITUTIONAL TEAR SHEET • REITWAVE.COM (v1.0.0) • Data Sources: SEC EDGAR Form 10-K / DEF 14A, PR Newswire, Bloomberg/CBRE Comps. For institutional and accredited investor due diligence. Not a solicitation or investment recommendation.